BioSpace News Archive

Codexis, Inc., a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences

Key Step Forward in Developing a Potential First-to-Market Pharmacologic Treatment for Myopia in Children

Genetic testing, educational materials and counseling offered at no charge to patients

Orchard Therapeutics, a global gene therapy leader, announced that the company is scheduled to present at the Barclays Gene Editing & Gene Therapy Summit on November 16, 2020 at 11:15 AM ET.

Signs agreement with SPI Medical for deployment of 630 Nanox.ARC units across Mexico and Guatemala; brings total contracted deployments to 5,150 across 13 countries

Trevena, Inc., a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system disorders, announced that management will participate in the following conferences in the month of November and invites investors to participate by webcast.

Treatment with AT-001 normalizes cardiac energetics and improves cardiac function in a mouse model of Diabetic Cardiomyopathy (DbCM)

Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM®, Verelan SR® and Verapamil PM

ASLAN Pharmaceuticals, a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced financial results for the third quarter ended September 30, 2020 and provided an update on its clinical activities.

A large, landmark study published in the American Cancer Society’s prestigious journal ‘Cancer Cytopathology’ shows that a simple non-invasive blood test can accurately differentiate between non-cancerous tumors versus cancerous growths.